Silvia Deaglio Selected Research

AT protocol

1/2022

Evaluation of Graft Fibrosis, Inflammation, and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: A Single-center Experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Deaglio Research Topics

Disease

38	Neoplasms (Cancer) 10/2022 - 04/2003
36	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2022 - 02/2002
7	Melanoma (Melanoma, Malignant) 10/2022 - 01/2016
6	Inflammation (Inflammations) 01/2022 - 03/2009
5	Hypoxia (Hypoxemia) 01/2021 - 01/2009
5	Disease Progression 01/2018 - 04/2003
4	Infections 01/2021 - 07/2008
3	Hematologic Neoplasms (Hematological Malignancy) 10/2019 - 01/2013
3	Leukemia 01/2018 - 07/2008
3	Lymphoma (Lymphomas) 01/2018 - 07/2009
3	Breast Neoplasms (Breast Cancer) 01/2016 - 05/2002
2	Reperfusion Injury 01/2022 - 01/2021
2	Obesity 01/2021 - 01/2020
2	Sepsis (Septicemia) 01/2021 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 09/2012 - 04/2010
2	Neuroblastoma 10/2011 - 04/2005
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Hyperhomocysteinemia 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Methylmalonic acidemia with homocystinuria 01/2022
1	Methylmalonic acidemia 01/2022
1	Atypical Hemolytic Uremic Syndrome 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	COVID-19 01/2021
1	Skin Neoplasms (Skin Cancer) 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2020
1	Acidosis 03/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2019
1	Multiple Myeloma 10/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Malignant Mesothelioma 01/2019

Drug/Important Bio-Agent (IBA)

8	Biological ProductsIBA 01/2020 - 04/2002
7	NAD (NADH)IBA 10/2022 - 03/2009
7	EnzymesIBA 10/2022 - 06/2011
7	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 12/2011
7	Pharmaceutical PreparationsIBA 03/2020 - 12/2011
6	LigandsIBA 11/2019 - 03/2003
5	Nicotinamide PhosphoribosyltransferaseIBA 10/2022 - 01/2015
4	CytokinesIBA 04/2018 - 06/2012
4	fludarabineIBA 06/2012 - 12/2010
3	AntibodiesIBA 01/2022 - 04/2005
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
3	ElementsIBA 01/2018 - 06/2008
3	NucleosidesIBA 01/2016 - 01/2011
3	Transferrin Receptors (Transferrin Receptor)IBA 04/2010 - 07/2007
2	AntigensIBA 01/2022 - 01/2017
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2017
2	Adenosine Triphosphate (ATP)IBA 04/2018 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 11/2016
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2018 - 07/2011
2	Interleukin-10 (Interleukin 10)IBA 11/2016 - 02/2015
2	Messenger RNA (mRNA)IBA 09/2012 - 05/2011
2	Hemoglobins (Hemoglobin)IBA 06/2012 - 09/2007
2	IronIBA 01/2009 - 07/2007
1	Dronabinol (THC)FDA LinkGeneric 10/2022
1	C-Reactive ProteinIBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	Heme (Haem)IBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Adenosine DeaminaseIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2020
1	ErbB Receptors (EGF Receptor)IBA 03/2020
1	Cetuximab (Erbitux)FDA Link 03/2020
1	AlarminsIBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Toll-Like Receptor 4IBA 11/2019
1	nicotinate phosphoribosyltransferaseIBA 11/2019
1	Small Interfering RNA (siRNA)IBA 10/2019
1	Sirtuin 3IBA 10/2019
1	Proteasome InhibitorsIBA 10/2019
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2019
1	MIA-690IBA 01/2019
1	Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	AsbestosIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 03/2018
1	Glycoproteins (Glycoprotein)IBA 03/2018
1	Signaling Lymphocytic Activation Molecule FamilyIBA 01/2018

Therapy/Procedure

19	Therapeutics 10/2022 - 02/2002
2	Drug Therapy (Chemotherapy) 11/2016 - 04/2003
1	Liver Transplantation 01/2022
1	Transplantation 01/2022
1	Precision Medicine 01/2022
1	AT protocol 01/2022
1	Organ Transplantation 01/2021
1	Immunotherapy 01/2021
1	Immunomodulation 03/2020